BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS Russian patent published in 2025 - IPC C07D281/10 C07D285/36 A61K31/554 A61P1/16 A61P3/06 A61P3/08 A61P5/00 A61P9/00 

Abstract RU 2837840 C1

FIELD: chemistry.

SUBSTANCE: group of inventions relates to organic chemistry and includes compounds: (Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-yl)oxy)-2-fluoroacrylic acid, (R)-(Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-fluoroacrylic acid, (S)-(Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-fluoroacrylic acid, (E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-sludge)oxy)acrylic acid, (S)-(E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (R)-(E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (R)-(Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (S)-(Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (Z)-3-((3-ethyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-yl)oxy)-2-fluoroacrylic acid, pharmaceutically acceptable salts thereof, a pharmaceutical composition based thereon and use.

EFFECT: technical result is 1,5-benzothiazepine derivatives possessing activity of inhibition of apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transporter (LBAT).

7 cl, 1 dwg, 8 tbl, 10 ex

Similar patents RU2837840C1

Title Year Author Number
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2838460C1
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2021
  • Gillberg, Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2841263C1
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-G&Ouml
  • Ran
  • Starke Ingemar
RU2827704C1
BENZOTHIA (DI) AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2838220C1
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg, Per-Joran
  • Mattson, Yan
  • Starke, Ingemar
  • Kulkarni, Santosh S.
RU2817535C2
BENZOTHIADIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS 2020
  • Gillberg Per-Goran
  • Starke Ingemar
  • Kulkarni Santosh S.
RU2838136C1
BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACIDS MODULATORS 2020
  • Gillberg, Per-Joran
  • Mattson, Yan
  • Starke, Ingemar
  • Kulkarni, Santosh S.
RU2814570C2
BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS 2019
  • Jillberg, Per-Jeran
  • Mattsson, Yan
  • Starke, Ingemar
  • Kulkarni, Santosh S.
RU2785867C2
PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER 2011
  • Jillberg Per-Jeran
  • Graffner Khans
  • Starke Ingemar
RU2619215C2
1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS 2001
  • Starke Ingemar
  • Dal'Strom Mikaehl'
  • Blomberg David
RU2302414C2

RU 2 837 840 C1

Authors

Gillberg Per-Goran

Starke Ingemar

Kulkarni Santosh S.

Dates

2025-04-07Published

2020-12-04Filed